Kirkland & Ellis LLP

Matt focuses on a wide range of antitrust matters, including complex transactions (and any related litigation), antitrust counseling, and government investigations. Matt is frequently relied upon to obtain regulatory clearance for many of the toughest, high profile deals. Representative clients and transactions include Bristol-Myers Squibb in its acquisition of Celgene, AbbVie in its pending acquisition of Allergan, Liqui-Box in its acquisition of DS Smith Plastics, Staples in its acquisition of Essendant, GlaxoSmithKline in its joint venture with Pfizer, Tronox in its acquisition of Cristal’s TiO2 business, Spectrum Brands’ sale of Rayovac to Energizer, Mazor Robotics’ sale to Medtronic, Sycamore Partners, Health Care Service Corporation, Blackstone, and Cinven.

Former Assistant Director, Federal Trade Commission, Bureau of Competition, Mergers IV Division (2007-2012); Deputy Assistant Director, Mergers I Division (2004-2007). Awarded the Chairman’s Award (the FTC’s highest honor) for numerous successes in high-profile litigations.

Georgetown University Law Center, J.D., 1995; Duke University, Sanford Institute of Public Policy, M.A., 1991; Colby College, B.A., 1988.